Theodore Ford, MD
Anesthesiology · Bend, ORNPI 1205940830
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $728 of the $816 with a category attached, or 89.1%. 11 manufacturers reported payments, led by Abbott at 25.4% of the total. Reporting peaked in 2019 at $394 and has fallen 95.7% since, to $17 in 2023. Among anesthesiology clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $21.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$207
- Amgen$125
- Arbor Pharmaceuticals, Inc.$113
- Pfizer$97
- Biodelivery Sciences International, Inc.$77
- AbbVie$61
- plus $136 from 5 others
What the payments were for
- Food & beverage$72889%
- Education$8911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 5 | $207 |
| Amgen | 1 | $125 |
| Arbor Pharmaceuticals, Inc. | 8 | $113 |
| Pfizer | 7 | $97 |
| Biodelivery Sciences International, Inc. | 5 | $77 |
| AbbVie(2 entities) | 4 | $61 |
| Si-bone, Inc. | 3 | $47 |
| Bioventus LLC | 2 | $32 |
| Merz North America, Inc. | 1 | $31 |
| Medtronic | 1 | $13 |
| Indivior Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVENITY$125
How this compares
$816 in reported general payments places this provider in the 90th percentile of 691 anesthesiology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 162 | $23,988 |
| BelbucaBuprenorphine Hcl | 21 | $18,649 |
| OxycontinOxycodone Hcl | 26 | $14,465 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 25 | $14,350 |
| Buprenorphine | 37 | $10,263 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 372 | $7,651 |
| MovantikNaloxegol Oxalate | 12 | $7,015 |
| Buprenorphine Hcl | 237 | $6,685 |
| Tramadol Hcl | 324 | $3,328 |
| Gabapentin | 250 | $2,770 |
| Oxycodone Hcl | 147 | $1,713 |
| Pregabalin | 124 | $1,626 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 62 | $1,399 |
| Cyclobenzaprine Hcl | 127 | $1,072 |
| Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol | 11 | $1,003 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Bend
- Kevin FlahertyBend$14K
- Nicholas ConnollyBend$13K
- Aris SophoclesBend$7K
- Timothy HolmbergBend$4K
- Evan SuttonBend$3K
- Todd RaudyBend$489
- Shawn SchumacherPortland$82K
- Neesa PatelPortland$41K
- Andrea OrfanakisPortland$10K
- David FromeCorvallis$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.